Skip to main content
OpenTrials
Completed

NCT Number: NCT01399437

Brain Functions Underlying Visuospatial Attention Deficits in Schizophrenia

Background:

- A special brain circuit is important for helping us keeping an eye open for things that are going on around us, even when we are not directly paying attention to them. This circuit seems to work differently in people with schizophrenia than in other people, which may explain specific deficits with broad monitoring observed in people with schizophrenia. Researchers want to compare brain function in people with schizophrenia and healthy volunteers to find out more about how these brain circuits work and affect attention.

Objectives:

- To study how the brain performs broad visual monitoring in people with schizophrenia.

Eligibility:

* Individuals between 18 to 55 years of age who have been diagnosed with schizophrenia. * Healthy volunteers between 18 and 55.

Design:

* Participants will be screened with physical and psychological exams. They will have a medical history. Tests for drug and alcohol use will also be done. * Participants will have two study visits. The first is a training visit and the second is a scanning visit. * At the training visit, participants will practice computer-based tests of focus, memory, and concentration. They will also answer questions about mood, psychiatric symptoms, and smoking habits. * At the scanning visit, participants will perform the computer-based tasks that they practiced at the training visit. They will have magnetic resonance imaging while they perform these tasks.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Schizophrenia Mental Disorders Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Maryland Psychiatric Research Center (MPRC) 55 Wade Avenue

Catonsville, Maryland, 21228, United States

About this study

Objective: To test a neural circuit explanation for a visuospatial attention abnormality seen in schizophrenia. Specifically, the aim is to test whether broad monitoring deficits may be based on a disruption of the so-called sentinel function of the default network. Because the default network is modulated by nicotinic compounds, such finding would implicate a possible remediation strategy.<TAB>

Study population: 24 people with schizophrenia, 24 matched healthy control subjects.

Design: A group comparison of attention task performance and associated brain activity as measured by functional Magnetic Resonance Imaging.

Outcome measures: Measures of attention task performance (reaction time, accuracy), BOLD signal within regions of the default network, degree of temporal association of BOLD signal with trial-by-trial reaction time.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

  • INCLUSION CRITERIA:

All participants:

  • Age 18 through 55.
  • Normal or corrected to normal visual acuity (at least 20/80)

Participants with menat illness:

  • DSM-IV diagnosis of schizophrenia or schizoaffective disorder
  • Ability to give written informed consent
  • Four week of stable pharmacological treatment (same psychiatric medication at same dose or no medication)

Exclusion criteria

All participants:

  • Presence of ferromagnetic metal objects in the body, implanted electronic devices or any other counter -indication for MRI.
  • Claustrophobia
  • Left handed or ambidextrous
  • History of myocardial infarction or heart failur, which may cause asymptomatic brain lesions
  • Uncontrolled high blood pressure (resting systolic greater than 150 or diastolic greater than 90 mm Hg)
  • Neurological conditions likely to impair cognitive function such as stroke, seizures, dementia or organic brian syndrome
  • Any condition likely to impair cognitive function such as mental retardation or severe pharmacological sedation
  • Current use of vasodilating beta-blockers (carvedilol, labetalol or nebivolol)
  • Alcohol or substance abuse or dependence other than nicotine within the last 6 months
  • Pregnancy, verified by urin pregnancy test for females during screening and on the day of the scan.

Healthy Controls:

  • Current psychiatric Axis I disorder or Axis II schizophrenia spectrum disorder, verified by Structured Clinical Interview for DSM-IV (SCID)

Treatment and study plan

Primary outcomes

  1. Behavioral performance measures on the cognitive tasks (e.g. reaction time, accuracy)

  2. Bold signal, specifically activation of the default network of resting brain function and its association with task performance.

Secondary outcomes

  1. Secondary outcome measures include ratings and scores on questionnaires and characterization tools.

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Registry information

Official study title

Default Network Dysfunction Underlying Visuospatial Attention Deficits in Schizophrenia

Important dates

Study start
2011
Study completion
2014
First posted
Jul 21, 2011
Registry last updated
Apr 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.